IDENTIFICATION ASSESSMENT AND THERAPY OF CANCERS WITH INNATE OR ACQUIRED RESISTANCE TO ALK INHIBITORS

摘要

The present application discloses whether a subject having a cancer (s) positive for an ALK mutation will respond to treatment with an ALK inhibitor and / or whether the patient with the cancer (s) can have a relatively slow disease progression Compositions, kits, and methods for determining are described. The present application further describes a method for predicting the time course of a disease in a patient having said cancer.